CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BridgeBio Pharma, Inc.

BBIO
$12.98BLarge Cap

Next catalyst

PDUFANov 27, 2026in 5 days

BBP-418

Limb-girdle muscular dystrophy type 2I/R9

Get an email about BBIO's next catalysts

Track BridgeBio Pharma (BBIO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 2 more upcoming events in our data (PDUFA date).See the timeline

Catalyst Timeline

3 upcoming, 1 past

PDUFANext

FDA PDUFA Date BBP-418

Nov 27, 2026BBP-418

For Limb-girdle muscular dystrophy type 2I/R9. NDA, Priority Review. Verified against the company announcement on 2026-10-16.

Source
PDUFA

FDA PDUFA Date Infigratinib (priority)

Feb 4, 2027Infigratinib

For children with achondroplasia. nda filing. Extracted from SEC filing: EXHIBIT 99.1

Source
PDUFA

FDA PDUFA Date encaleret (standard)

May 8, 2027Encaleret

For autosomal dominant hypocalcemia type 1 (ADH1). NDA filing. Extracted from SEC filing: EXHIBIT 99.1

Source

Upcoming FDA decisions

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaPALO ALTO725 employees
Drug Pipeline

Frequently asked questions

What is in BridgeBio Pharma, Inc.'s drug pipeline?β†’

CatalystAlert tracks 4 drug candidates in BridgeBio Pharma, Inc.'s (BBIO) pipeline across Phase 3, Phase 2. Its lead program is Infigratinib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is BridgeBio Pharma, Inc.'s next FDA catalyst?β†’

BridgeBio Pharma, Inc.'s (BBIO) next tracked catalyst is a PDUFA date expected Nov 27, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track BBIO biotech catalysts?β†’

Add BBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BridgeBio Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply